Βιογραφικό Σημείωμα
Antonia V. Charchanti
Born:
February 24, 1969
Trikala, Greece
Citizenship:
Greek
Office Address :
Department of Anatomy-Histology-Embryology
University of Ioannina
School of Medicine
45110 Ioannina, Greece
Tel.
26510-97832
FAX:
26510-97861
E-mail:
acharcha@cc.uoi.gr
Education
11/1994:
Medical Degree
University of Ioannina
School of Medicine
12/1994-07/2001:
Residency, Pathology
Dept of Pathology, Univeristy of Ioannina
School of Medicine
05/1998-05/1999:
Residency, Cytology
Dept of Pathology, Univeristy of Ioannina
School of Medicine
03-04/1999:
Research Fellow, Electron Microscopy
Christie Hospital NHS Trust,Manchester, U.K
Dr. Brian Eyden
Head of Diagnostic Electron Microscopy
Department of Histopathology Christie Hospital NHS Trust
Manchester-U.K. (grant)
07/1999:
Research Fellow, Electron Microscopy
Christie Hospital NHS Trust,Manchester, U.K
Dr. Brian Eyden
Head of Diagnostic Electron Microscopy
Department of Histopathology Christie Hospital NHS Trust
Manchester-U.K. (grant)
01-03/2003:
Research Fellow, Electron Microscopy
Dept of Electron Microscopy, Research Center of «G
Papanikolaou» at St. Savas Hospital, Athens
06/2002:
Degree, Doctor of Science
Dept of Pathology, Univeristy of Ioannina
School of Medicine
2
Post-Doctoral Training
1.
“Borderline lesions and tumors"
Postgraduate Course,
organized by the European School of Oncology
6-8 April 1995, Athens, Greece
2.
΄΄Stromal reaction in preneoplastic and early cancerous lesions΄΄
European Course of Cellular Pathology
supported by
the European Society of Pathology (ESP)
and the European Cell Biology Organization (ECBO),
in collaboration with the European School of Oncology (ESO),
9-14 May 1997, Metsovo, Ioannina / Greece *
3.
Part I-General Pathology
Postgraduate Course in theoretical and diagnostic histopathology
organized by
the departments of Pathology of the Democritus University of Thrace
and the University of Ioannina / Greece
in collaboration with the St.Bartholomew’s
and the Royal London School of Medicine and Dentistry of the University of
Sheffield Medical School, U.K. 10-14
September 1998, Alexandroupolis, Greece
4.
΄΄Lung Pathology – Oncology΄΄
Ioannina University Courses in Pathology (IUCP)
13-17 October 1998, Ioannina *
5.
΄΄Breast Pathology – Oncology΄΄
Ioannina University Courses in Pathology (IUCP)
11-15 May 1999, Ioannina *
6.
΄΄Prostate Pathology – Oncology
Ioannina University Courses in Pathology (IUCP)
12-16 October 1999, Ioannina *
7.
΄΄Thyroid Pathology – Oncology΄΄
Ιoannina University Courses in Pathology (IUCP)
22-24 May 2000, Ioannina *
8.
΄΄Salivary glands Pathology – Oncology΄΄
Ioannina University Courses in Pathology (IUCP)
18-20 May 2000, Ioannina *
9.
΄΄Oesophagus-Stomach Pathology – Oncology΄΄
Ioannina University Courses in Pathology (IUCP)
15-17 May 2001, Ioannina *
10.
΄΄Duodenum-Biliary tract-Pancreas Pathology – Oncology΄΄
Ioannina University Courses in Pathology (IUCP)
17-19 May 2001, Ioannina *
11.
΄΄Small intestine Pathology – Oncology΄΄
Ioannina University Courses in Pathology (IUCP)
3
28-29 May 2002, Ioannina *
12.
΄΄Large intestine Pathology – Oncology΄΄
Ioannina University Courses in Pathology (IUCP)
30 May -01 June 2002, Ioannina *
Professional Appointments
03/2003-9/2003:
Consultant, Pathologist
General Hospital – Medical Center Filiaton
Thespotria
09/2003-2009:
Lecturer
Department of Anatomy-Histology-Embryology
University of Ioannina
School of Medicine
2009-today
Assistant Professor
Department of Anatomy-Histology-Embryology
University of Ioannina
School of Medicine
Medical Societies and Associations
1. European Society of Pathology
2. Hellenic Anti-Cancer Society
Research Grants
08/1999-10/1999:
Collaborator
''Development of Pathology Training System»
Work-program Νο 665 TEMETEN
Towards a European medical and teleworking network,
06/2006-04/2009:
Prinicipal Investigator
Pro-herbs
Work-Program Interreg IIIB Archimed (Ε.Ε. 63/2077)
2008-2009
Collaborator
University Structural Support 2007-2008,
Programs of Academic Excellence University of Ioannina
“Neural cell death – examination of molecular mechanisms of apoptosis
using tissue microarrays”. 251,200.00Ε
4
Publications
1. Ioachim E., Charchandi A., Stavropoulos N.E., Athanassiou E.and Agnantis N. J..
Expression of the cell adhesion molecule CD44 in transitional cell carcinoma of the urinary
bladder. Journal of Tumor Marker Oncology 1997; 12 (4): 27-36,
2. Skopelitou Α., Mylonakis E,. Charchanti A, Kappas A.. Cellular Neurilemoma
(Schwannoma) of the Descending Colon Mimicking Carcinoma. Dis Colon Rectum 1998;
41(9): 1193-96
3. .Eyden B, Yamazaki K., Menasce L.P, Charchanti A., Agnantis N. J. Basement-membranerelated peri-vascular matrices not organised as a basal lamina: distribution in malignant
tumours and benign lesions J. Submicrosc. Cytol. Pathol. 2000; 32 (4), 515-523,
4. Ioachim E., Charchanti A., Stavropoulos N. E.,. Skopelitou A, Athanassiou E. D. and
Agnantis N. J. Immunohistochemical expression of Retinoblastoma gene product (Rb), p53
protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder
arcinoma Histol Histopathol 2000; 15: 721-727
5. Tatsioni A., Charchanti A, Kitsiou E, Ioannidis PA J. Appendicectomies in Albanians in
Greece: outcomes in a highly mobile immigrant patient population BMC Health Services
Research 2001 1:5
6. .Ioachim E,.Charchanti A,. Stavropoulos N, Athanassiou E, Michael M., and Agnantis N.
Localization of metallothionein in urothelial carcinoma of the human urinary bladder: An
immunohistochemical study including correlation with HLA-DR antigen p53, and proliferation
indices. Anticancer Research 2001 May-Jun;21(3B):1757-61.
7. Stavropoulos N, Ioachim E, Charchanti A, Michael M., Kitsiou E., Mihailidis I., Hastazeris K.
and Agnantis N.. Tumor Markers in Stage P1 Bladder Cancer Anticancer Research 21:
1495-1498 (2001)
8. Ioachim E., Charchanti A., Briasoulis E., Karavasilis V., Tsanou H., Arvanitis D. L., Agnantis
N.J and Pavlidis N. Immunohistochemical expression of extracellular matrix components
tenascin, fibronectin, collagen type IV and laminin in breast cancer: Their prognostic value
and role in tumor invasion and progression. Eur J Cancer 2002 Dec; 38 (18): 2362-70
9. Ioachim E., Charchanti A., Stavropoulos N., Athanassiou E., Bafa M. and. Agnantis N. J.
Expression of cathepsin D in urothelial carcinoma of the urinary bladder: An
immunohistochemical study including correlations with extracellular matrix components,
CD44, p53, Rb, c-erbB-2 and the proliferation indices. Anticancer Research 2002 Nov-Dec;
22 (6A): 3383-8
10. Kalef-Ezra J., Michalis L.K., Malamou-Mitsi V., Tsekeris P., Katsouras C., Boziari A.,
Toumpoulis I., Bozios G., Charchanti A., Sideris D.A.. External beam irradiation in
angioplasted arteries of hypercholesterolemic rabbits. The dose and time effect. Cardiovasc
Radiat Med. 2002 Jan-Mar; 3 (1): 20-25
11. Ioachim E., Tsanou H.,. Briasoulis E, Batsis Ch., Karavasilis V., Charchanti A., Pavlidis
N.and Agnantis N.J.. Clinicopathological study of the expression of hsp27 and pS2,
Cathepsin D and metallothionein in primary invasive breast cancer. Breast 2003 Apr;
12(2):111-9.
12. Ioachim E., Charchanti A., Charalabopoulos K., Tsanou H., Briasoulis E., Karavasilis V.,
Pavlidis N.,. Agnantis N J. The prognostic evaluation of tumor angiogenesis in invasive
5
breast carcinoma Electronic Journal of Pathology and Histology Volume 8, Numbers 14/2002/2003 \
13. Charchanti A., Ioachim E., Eyden B., and Agnantis N. J. Ultrastructural and
immunohistochemical observations on amorphous matrices related to basal lamina in breast
cancer: preliminary data. Electronic Journal of Pathology and Histology Volume 8, Numbers
1-4/2002/2003
14. Ioachim E, Charchanti A, Briasoulis E, Karavasillis V., Batsis C.,, Pavlidis N and Agnantis
NJ. The prognostic value of vascular endothelial growth factor (VEGF) in invasive breast
cancer: Correlation with microvessel density (MVD), ER, PgR, p53 and proliferative
associated indices (Ki-67, PCNA) 2002;. Electronic Journal of Pathology and Histology 8
(4), pp. 24071-2400710
15. Tsanou E, Ioachim E, Briasoulis E, Damala K, Charchanti A, Karavasilis V, Pavlidis N,
Agnantis NJ. Immunohistochemical expression of superoxide dismutase (MnSOD) antioxidant enzyme in invasive breast carcinoma. Histol Histopathol. 2004 Jul;19(3):807-13.
16. Tsanou E, Ioachim E, Briasoulis E, Charchanti A, Damala K, Karavasilis V, Pavlidis N,
Agnantis NJ. Clinicopathological study of the expression of syndecan-1 in invasive breast
carcinomas. Correlation with extracellular matrix components. J Exp Clin Cancer Res. 2004
Dec;23(4):641-50.
17. Kitsoulis P, Vlychou M, Papoudou-Bai A, Karatzias G, Charchanti A, Agnantis NJ, Bai M.
Primary lymphomas of bone. Anticancer Res. 2006 Jan-Feb;26(1A):325-37. Review.
18. Polyzos PT, Arvanitis LD, Charchanti A, Galani V, Havaki S, Kallioras VA, Nakou M, Faros
EG, Marinos E, Sgantzos MN, Kittas C. Decidualized and pre-decidualized normal
endometrial stromal cells produce more O-linked N-acetylglucosamine containing epitope H
than non-decidualized normal endometrial stromal cells. Histol Histopathol. 2006
Nov;21(11):1193-8.
19. Sgantzos MN, Galani V, Arvanitis LD, Charchanti A, Psathas P, Nakou M, Havaki S,
Kallioras V, Marinos E, Vamvakopoulos NC, Kittas C.Expression of the O-linked Nacetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle
cell tumors. Pathol Res Pract. 2007;203(1):31-7. Epub 2006 Nov 28.
20. Ananiadou OG, Bibou K, Drossos GE, Charchanti A, Bai M, Haj-Yahia S, Anagnostopoulos
CE, Johnson EO. Effect of profound hypothermia during circulatory arrest on neurologic
injury and apoptotic repressor protein Bcl-2 expression in an acute porcine model.J Thorac
Cardiovasc Surg. 2007 Apr;133(4):919-26. Epub 2007 Feb 22
21. Kitsoulis P, Charchanti A, Paraskevas G, Marini A, Karatzias G. Adamantinoma. Acta
Orthop Belg. 2007 Aug;73(4):425-31. Review.
22. Johnson EO, Charchanti A, Soucacos PN. Nerve repair: experimental and clinical
evaluation of neurotrophic factors in peripheral nerve regeneration. Injury. 2008 Sep;39
Suppl 3:S37-42. Epub 2008 Aug 23
23. Johnson EO, Charchandi A, Babis GC, Soucacos PN. Apoptosis in osteoarthritis:
morphology, mechanisms, and potential means for therapeutic intervention. J Surg Orthop
Adv. 2008 Fall;17(3):147-52.
24. Ananiadou OG, Bibou K, Drossos GE, Bai M, Haj-Yahia S, Charchardi A, Johnson EO.
Hypothermia at 10 degrees C reduces neurologic injury after hypothermic circulatory arrest
in the pig. J Card Surg. 2008 Jan-Feb;23(1):31-8.
25. , Charchanti A, Verillis P., Ioachim E., Ananiadou OG, Johnson EO. Electron Microscopy
evidence of Apoptosis after hypothermic circulatory arrest in the pig. (Submitted)
6
Proceedings
1. Malamou-Mitsi V, Ioachim E.,. Kamina S,. Skopelitou A,. Charchanti A and Agnantis. N.
J.Immunohistochemical study of cell proliferation and apoptosis markers in breast neoplasia.
Anticancer Research, Vol. 17: 4012-4013, 1997
2. Ioachim E,. Charchanti A,. Stavropoulos N. E, and Agnantis. N. J. Immunohistochemical
expression of extracellular matrix component and Cathepsin D: A correlation with p53, Rb, cerbB-2 and the proliferative activity in the urinary bladder cancer. Anticancer Research Vol.
18: (6) 4883-4884, 1998.
3.
Skopelitou A., Kamina S,. Charchandi A, and. Agnantis N. J. Immunohistochemical
expression of the Retinoblastoma Gene Product in 110 Urinary Bladder Transitional Cell
Carcinomas: A reliable prognostic marker in patients’ clinical outcome. Journal of Pathology
Supplement 1998; 40A
4. Goussia A., Kordela V., Sintou–Mantela E., Zioga K., Panelos I., Charchanti A., Dimou S.,.
Agnantis N.J, Bai M.. Expression of cell cycle proteins in bladder carcinomas Virchows Arch
447 (2): 700, 2005
5. Charchanti A., Goussia A., Balasi E., Zioga C., Fountzilas G., Kanavaros P., Agnantis N.,
Bai M.. Immunohistochamical expression of syndecan-1 protein in gastric cancer. Virchows
Arch 448 (5): 723, 2006.
6. Lampri E., Goussia A., Sintou-Mantela E., Balasi E., Charchanti A., Kamina S., Capizzelo
A., Tsekeris P., Briasoulis E., Malamou-Mitsi V.,. Agnantis N.J, Bai M.. Microvessel density
and expression of angiogenic proteins VEGF, VEGFR1 and VEGFR2 in gastric
adenocarcinoma. Virchows Arch 451 (2): 321, 2007.
Chapters
1. Charchanti A., Soucacos P.N., Johnson E.O., Primary Histological Features in Acute
and Chronic Infections, Infections of the Hand & Upper Limb, 2007, PMP(Paschalidis
Medical Publications Ltd.)
2. Plissiti M. E, Charchanti A., Krikoni O., and Fotiadis D.I., “Automated segmentation of
cell nuclei in PAP smear images,” IEEE, itab 2006, 26-28 October, Ioannina
3. Plissiti M.E., Tripoliti E.E., Charchanti A., Krikoni O. and Fotiadis D.I., Automated
Detection of Cell Nuclei in PAP Stained Cervical Smear Images using Fuzzy Clustering,
eMBEC 2008, 23-27 November, FC&CC, Antwerp, Belgium
Chapters in Post-Doctoral Course Texts
1. Charchanti A., “Anatomy and Histology of the Endometrium, Ovaries and Accessories”
Ιoannina University Courses in Pathology (IUCP)., Second Series, Endometrium, Ovaries
and Accessories Pathology-Oncology, May 27-28, 2004, Ioannina
2. Charchanti A., “The normal breast: Anatomy, Histology and Function”, Ιoannina
University Courses in Pathology (IUCP)., Second Series, Breast Pathology-Oncology,
November 2-4, 2005, Ioannina
3. Charchanti A.,“The normal prostate: Histology and Function” Ιoannina University
Courses in Pathology (IUCP)., Second Series, Prostate, Pathology-Oncology, May 25-27,
2005, Ioannina
4. Charchanti A.,“The anatomy of the Pleura and Mediastinum” Ιoannina University
Courses in Pathology (IUCP)., Second Series, Pleura & Mediastinum PathologyOncology 4-5 June, 2009, Ioannina
7
Abstracts (International Meetings)
1.
E, Kamina S, Charchanti A, Athanassiadou S and Agnantis N. J. Immunohistochemical
glycoprotein CD44 expression in human breast cancer in correlation with the Basement
Membrane antigens, Fibronectin, Cathepsin D, P53, C-erbB-2, proliferating indices, steroid
receptor content as well as with the other conventional clinicopathological parameters in
breast cancer. Euro cell Path - European School of Oncology Metsovo, Ioannina Greece 914 May 1997 (awarded)
2.
Ioachim E, Kamina S, Athanassiadou S, Charchanti A and Agnantis N. J.
Immunohistochemical expression of type IV Collagen, Laminin, Fibronectin and Cathepsin D:
Correlation of proliferative activity, steroid receptors content and its clinicopathological
significance in breast cancer. Euro cell Path - European School of Oncology Metsovo,
Ioannina Greece 9-14 May 1997
3.
V. Malamou-Mitsi, E. Ioachim, S. Kamina, A. Skopelitou, A Charchanti and N J. Agnantis.
Immunohistochemical study of cell proliferation and apoptosis markers in breast neoplasia.
6th Hellenic Congress on Senology Alexandroupolis Greece, 12-16 June 1997
4.
V. Malamou-Mitsi, E. Ioachim, S. Kamina, A. Skopelitou, A Charchanti and N J. Agnantis.
Immunohistochemical study of cell proliferation and apoptosis markers in breast neoplasia.
Ιinternational Conference Organized and Supported by the International Institute of
Anticancer Research. Apoptosis meeting Athens, Greece 2-5 October 1977.
5.
E. Ioachim, A. Charchandi, N.E. Stavropoulos, A. Christodoulou and N. J. Agnantis.
Immunohistochemical expression of extracellular matrix component and Kathepsin-D:a
correlation with P53, Rb, C-ERBB-2 and the proliferative activity in the urinary bladder
cancer. XXVth Balkan Medical Week Ioannina 1-4 July 1998, Greece.
6.
E. Ioachim, A. Charchandi, N. E. Stavropoulos and N. J. Agnantis Localization of
metallothionein in human urinary bladder carcinoma: An immunohistochemical study
including correlation with HLA-DR antigen, p53, Rb and proliferating indices. XXVth
Balkan Medical Week Ioannina 1-4 July 1998, Greece. (Η εργασία αυτή βραβεύτηκε
από την επιστημονική επιτροπή του συνεδρίου)
7.
E. Ioachim, A. Charchandi, N. E. Stavropoulos, A. Christodoulou and N. J. Agnantis.
Immunohistochemical expession of extracellular matrix component and CathepsinD: a
correlation with P53, Rb, C-ERBB-2 and the proliferative activity in the urinary bladder
cancer. 6th International Conference of Anticancer Research Halkidiki 21-25 October
1998, Greece.
8.
A.S.Skopelitou, S.Kamina, A. Charchanti, N.J.Agnantis. Immunohistochemical
expression of the Retinoblastoma gene product in 110 Urinary Bladder Transitional Cell
Carcinomas: A reliable prognostic marker in patients’ clinical outcome. Pathological
Society of Great Britain and Ireland, 176th Meeting, 7-9 January 1998, Synopses of
papers, pp 40A
9.
E. Ioachim, A. Charchanti, N.E. Stavropoulos, A. Skopelitou, E. Athanassiou and N. J.
Agnantis. Ιmmunohistochemical expression of Retinoblastoma gene product (RB), p53
protein, MDM2, C-ERBB-2, HLA-DR and proliferation indices in human urinary bladder
carcinoma. Pathological Society of Great Britain and Ireland Dundee, Summer Meeting
7th –9th July 1999
10. A.Charchanti , E. Ioachim, B. Eyden and N.J. Agnantis Ultrastructural and
immunohistochemical observations on amorphous matrices related to basal lamina in
8
breast cancer.
Euroworkshop I on Interdisciplinary Perspectives of Diagnostic
Pathology, Cell Biology, and Morphometry Heidelberg, December 8-10, 2000
11. Α. Charchanti, E. Ioachim, N.J. Agnantis Immunohistochemical expression of extracellular
matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: The
prognostic value and their role in tumor expansion and progression Euroworkshop II on
Interdisciplinary Perspectives of Diagnostic Pathology, Cell Biology, and Morphometry
Bruxelles, October 5-7, 2001
12. Charchanti A, Ioachim E, Briasoulis E and NJ Agnantis. Angiogenesis in invasive breast
carcinoma: Association with extracellular matrix components and proteolytic enzymes.
Euroworkshop II onInterdisciplinary Perspectives of Diagnostic Pathology, Cell Biology, and
Morphometry Brussels, October 5-7, 2001
13. Ioachim E, Charchanti A, Briasoulis E, Karavasilis V, Τsanou H and N.J. Agnantis
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin,
collagen type IV and laminin in breast cancer: The prognostic value And their role in tumor
expansion and progression. HSBCR 5th INTERNATIONAL CONGRESS ‘where we stand
with breast cancer research’ Athens, 1-2 November, 2001
14. Α. Charchanti, E Ioachim, Eyden B, and N.J. Agnantis
Ultrastructural and
immunohistochemical observations on amorphous matrices related to basal lamina in breast
cancer. HSBCR 5th INTERNATIONAL CONGRESS ‘where we stand with breast cancer
research’ Athens, 1-2 November, 2001
15. Charchanti A, Ioachim E, Briasoulis E and NJ Agnantis. Angiogenesis in invasive breast
carcinoma: Association with extracellular matrix components and proteolytic enzymes.
HSBCR 5th INTERNATIONAL CONGRESS ‘where we stand with breast cancer research’
Athens, 1-2 November, 2001
16. A. Charchanti, E. Ioachim and N.J. Agnantis Clinical significance of vascular endothelial
growth factor (VEGF) and microvessel density (MVD) in breast cancer. Euroworkshop III on
Interdisciplinary Perspectives of Diagnostic Pathology, Cell Biology, and Morphometry
Madrid, December 6-8, 2002
17. Charchanti A., Ioachim E and Agnantis NJ. Clinical significance of vascular endothelial
Growth Factor (VEGF) and Microvessel Density (MVD) in Breast Cancer2.2nd International
Mediterranean Course in Mastοlogy, September 25-26, 2003, Ioannina (Η εργασία αυτή
βραβεύτηκε από την επιστημονική επιτροπή του συνεδρίου)
18. Goussia A., Kordela V., Sintou–Mantela E., Zioga K., Panelos I., Charchanti A., Dimou S.,.
Agnantis N.J, Bai M.. Expression of cell cycle proteins in bladder carcinomas (Περ. αρ.
P375).20th European Congress of Pathology September 3-8, Paris, France
19. Charchanti A., Goussia A., Balasi E., Zioga C., Fountzilas G., Kanavaros P., Agnantis N.,
Bai M. .Immunohistochemical expression of syndecan-1 protein in gastric cancer (Περ. αρ.
P207).2nd Inter-Congress of the European Society of Pathology May 24-27, Ioannina
20. Bibou K, Ananiadou OG, Charchanti A, Drossos GE, Bai M, Johnson EO. Profound
hypothermic circulatory arrest is associated with increased Bcl-2 immunoreactivity in
selectively vulnerable brain regions, 2nd Inter-Congress of the European Society of
Pathology May 24-27, Ioannina
21. Doukas M, Papoudou-Bai A, Lampri E, Kamina S., Charchanti A., Rontogianni D., Agnantis
NJ., P. Kanavaros, , M. Bai. Apoptosis Profile of normal human thymus. 2nd Inter-Congress
of the European Society of Pathology May 24-27, Ioannina
9
22. Plissiti M. E, Charchanti A., Krikoni O., and Fotiadis D.I., “Automated segmentation of cell
nuclei in PAP smear images,” in proc. IEEE International Special Topic Conference on
Information Technology in Biomedicine, Greece, Oct. 26-28, 2006.
23. Lampri E., Goussia A., Sintou-Mantela E., Charchanti A., Capizzelo A., Tsekeris P.,
Briasoulis E., Malamou-Mitsi V., Agnantis N.J., Bai M.. Microvessel density and expression
of angiogenic proteins VEGF, VEGFR1 and VEGFR2 in gastric adenocarcinoma (Περ. αρ.
P28)1st Hellenic-Jordanian Congress of Pathology April 29-30, Crete
24. Lampri E., Goussia A., Sintou-Mantela E., Balasi E., Charchanti A., Kamina S., Capizzelo
A., Tsekeris P., Briasoulis E., Malamou-Mitsi V., Agnantis N.J., Bai M.. Microvessel density
and expression of angiogenic proteins VEGF, VEGFR1 and VEGFR2 in gastric
adenocarcinoma (Περ. αρ. PP2-103). 21st European Congress of Pathology September 813, Instabul, Turkey
25. Koutsogiannidis H.,. Ananiadou O.G,. Bibou A.N, Charchanti A., Bai M., Drossos G.E.,
Johnson E.O., Neuroprotection with profound hypothermia to 10 C during hypothermic
circulatory arrest in an acute porcine model measures of apoptosis in the primary cortex.
14th World Congress on Heart Disease, Toronto, On, Canada, July 26-29, 2008
26. Plissiti M.E., Tripoliti E.E., Charchanti A., Krikoni O. and Fotiadis D.I., Automated Detection
of Cell Nuclei in PAP Stained Cervical Smear Images using Fuzzy4th European Congress
for Medical and Biomedical Engineering, 23 – 27 November 2008, Antwerp, The
Netherlands.
10